One reason is the rapid development of scientific disciplines, such as molecular biology, microbiology, cell biology, developmental biology, immunology, etc., which produce novel subject matter to be protected. 

Examples include cloned genes, nucleic acid probes, transgenic and cloned animals, gene chips, monoclonal antibodies, chimeric antibodies, humanized antibodies, enzymes, and the uses of many of these novel materials in diagnostics, therapeutics and the production of still further materials.

Another reason is that intellectual property law has changed remarkably since the 1980 landmark Supreme Court decision in the Chakrabarty case which held that living organisms are patentable subject matter.

Many of the developments in intellectual property law have a unique application to

Our firm has earned its reputation based on the extensive training and experience, both scientific and legal, of its professional staff.

We strive to obtain for our clients the best protection available through a thorough and creative approach in preparing and prosecuting patent applications, negotiating and drafting license agreements, collaborative research, development and marketing agreements, materials transfer agreements and other types of agreements relating to biotechnology.

The scientific education and industry experience coupled with the legal education and experience of our attorneys and technical advisors at Jondle & Associates enable them to develop unique strategies to protect our clients' inventions.